English | Español
Press release submission | Oct 31, 2021

HOPSTEM completed 40 million USD series B financing, to develop safe, effective and affordable iPSC cell therapies for global patients

Press release submission | Oct 30, 2021

Akebia Announces Otsuka's Submission of Initial Marketing Authorization Application to the European Medicines Agency for Vadadustat for the Treatment of Patients with Anemia due to Chronic Kidney Disease

Press release submission | Oct 29, 2021

Banty's Dr. Richard Tytus Explains How to Have Successful Virtual Medicine Appointments with Patients

Press release submission | Oct 29, 2021

HUYABIO Announces FDA Clearance to Initiate a Phase 1 Trial of SHP2 Inhibitor in Patients with KRAS and EGFR Mutated Tumors
Bob Martin | Oct 29, 2021

American Foundation for Suicide Prevention to spend $6.44 million on research this year
Press release submission | Oct 28, 2021

New Outcomes Data Demonstrating Prolonged Survival for Inoperable Pancreatic Cancer Patients Presented at Leading Radiation Oncology Meeting

Karla Florez | Oct 28, 2021

FirstNet partners with AT&T to launch program for first responders who 'put their lives on the line every day'
Bob Martin | Oct 27, 2021

Study shows 'promising new findings' for psilocybin therapy for depressed cancer patients

Trending
Patient Daily | Nov 5, 2025

Pacific Research Institute CEO on misuse of 340B funds: ‘340B was meant to help low-income patients'
+ Pharmaceuticals
Patient Daily | Nov 6, 2025

Mark Cuban on PBMs: ‘Patients are getting ripped off because PBMs and wholesalers insist on using inflated list prices'
Patient Daily | Nov 5, 2025

Riley Gaines on 340B program: ‘Blue states are using taxpayer dollars to fund unregulated child mutilation procedures’
+ Pharmaceuticals
Patient Daily | Nov 3, 2025

Patient groups urge Congress to renew enhanced premium tax credits before open enrollment